

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 7.07593538 |
| 2 | C21-steroid hormone biosynthetic process (GO:0006700) | 5.81840650 |
| 3 | forebrain neuron differentiation (GO:0021879) | 5.08509785 |
| 4 | anterior/posterior axis specification, embryo (GO:0008595) | 4.79299739 |
| 5 | organ induction (GO:0001759) | 4.57831027 |
| 6 | nonmotile primary cilium assembly (GO:0035058) | 4.44939282 |
| 7 | regulation of development, heterochronic (GO:0040034) | 4.30979667 |
| 8 | mitochondrial fission (GO:0000266) | 4.26862104 |
| 9 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 4.13057920 |
| 10 | positive regulation of cardiac muscle cell proliferation (GO:0060045) | 4.04434456 |
| 11 | acrosome assembly (GO:0001675) | 4.01649525 |
| 12 | regulation of timing of cell differentiation (GO:0048505) | 3.73630798 |
| 13 | DNA double-strand break processing (GO:0000729) | 3.72877659 |
| 14 | positive regulation of cardiac muscle tissue growth (GO:0055023) | 3.71771409 |
| 15 | olfactory bulb development (GO:0021772) | 3.71100837 |
| 16 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 3.54430432 |
| 17 | regulation of sulfur metabolic process (GO:0042762) | 3.52587520 |
| 18 | regulation of sister chromatid cohesion (GO:0007063) | 3.47783320 |
| 19 | regulation of mesoderm development (GO:2000380) | 3.46120886 |
| 20 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.42240397 |
| 21 | mammary gland alveolus development (GO:0060749) | 3.40498792 |
| 22 | progesterone metabolic process (GO:0042448) | 3.37603882 |
| 23 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.35249224 |
| 24 | regulation of cardiac muscle cell proliferation (GO:0060043) | 3.21283818 |
| 25 | mammary gland epithelial cell differentiation (GO:0060644) | 3.19683681 |
| 26 | positive regulation of heart growth (GO:0060421) | 3.19312173 |
| 27 | embryonic foregut morphogenesis (GO:0048617) | 3.18367584 |
| 28 | positive regulation of cardiac muscle tissue development (GO:0055025) | 3.17066629 |
| 29 | regulation of coenzyme metabolic process (GO:0051196) | 3.15750684 |
| 30 | regulation of cofactor metabolic process (GO:0051193) | 3.15750684 |
| 31 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 3.12133265 |
| 32 | regulation of cardioblast proliferation (GO:0003264) | 3.12133265 |
| 33 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.10900786 |
| 34 | axoneme assembly (GO:0035082) | 3.05616849 |
| 35 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 2.98317927 |
| 36 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.98082867 |
| 37 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.97128747 |
| 38 | developmental induction (GO:0031128) | 2.96350958 |
| 39 | lymphangiogenesis (GO:0001946) | 2.95367652 |
| 40 | regulation of cilium movement (GO:0003352) | 2.94653869 |
| 41 | regulation of organ formation (GO:0003156) | 2.92371026 |
| 42 | cilium morphogenesis (GO:0060271) | 2.92299081 |
| 43 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 2.91877306 |
| 44 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.90581045 |
| 45 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.84188758 |
| 46 | anterior/posterior axis specification (GO:0009948) | 2.83998307 |
| 47 | embryonic heart tube development (GO:0035050) | 2.82682032 |
| 48 | response to lipoprotein particle (GO:0055094) | 2.82616910 |
| 49 | retinal ganglion cell axon guidance (GO:0031290) | 2.81120654 |
| 50 | cell-cell signaling involved in cell fate commitment (GO:0045168) | 2.80658671 |
| 51 | regulation of cardioblast differentiation (GO:0051890) | 2.80465405 |
| 52 | positive regulation of mitochondrial fission (GO:0090141) | 2.80082172 |
| 53 | chromatin remodeling at centromere (GO:0031055) | 2.78568440 |
| 54 | embryonic pattern specification (GO:0009880) | 2.77322491 |
| 55 | ventricular cardiac muscle cell development (GO:0055015) | 2.74393681 |
| 56 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.70087396 |
| 57 | photoreceptor cell maintenance (GO:0045494) | 2.69640336 |
| 58 | CENP-A containing nucleosome assembly (GO:0034080) | 2.63208574 |
| 59 | lung-associated mesenchyme development (GO:0060484) | 2.61867516 |
| 60 | behavioral defense response (GO:0002209) | 2.58982890 |
| 61 | behavioral fear response (GO:0001662) | 2.58982890 |
| 62 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.57109999 |
| 63 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.56581528 |
| 64 | limb development (GO:0060173) | 2.51143625 |
| 65 | appendage development (GO:0048736) | 2.51143625 |
| 66 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.49922361 |
| 67 | negative regulation of response to food (GO:0032096) | 2.49854032 |
| 68 | negative regulation of appetite (GO:0032099) | 2.49854032 |
| 69 | regulation of cardiac muscle tissue growth (GO:0055021) | 2.49760207 |
| 70 | organ formation (GO:0048645) | 2.48641978 |
| 71 | glial cell proliferation (GO:0014009) | 2.47365913 |
| 72 | bone trabecula formation (GO:0060346) | 2.44963522 |
| 73 | hyperosmotic salinity response (GO:0042538) | 2.43468315 |
| 74 | positive regulation of muscle organ development (GO:0048636) | 2.43053059 |
| 75 | positive regulation of striated muscle tissue development (GO:0045844) | 2.43053059 |
| 76 | midgut development (GO:0007494) | 2.41340168 |
| 77 | short-term memory (GO:0007614) | 2.41295545 |
| 78 | pyrimidine dimer repair (GO:0006290) | 2.40507813 |
| 79 | regulation of centriole replication (GO:0046599) | 2.38409387 |
| 80 | regulation of mRNA splicing, via spliceosome (GO:0048024) | 2.37937713 |
| 81 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.37479770 |
| 82 | regulation of tight junction assembly (GO:2000810) | 2.36056132 |
| 83 | regulation of alternative mRNA splicing, via spliceosome (GO:0000381) | 2.36055228 |
| 84 | sister chromatid segregation (GO:0000819) | 2.35366613 |
| 85 | positive regulation of muscle tissue development (GO:1901863) | 2.34385432 |
| 86 | chondrocyte proliferation (GO:0035988) | 2.33700520 |
| 87 | negative regulation of cell fate specification (GO:0009996) | 2.33173784 |
| 88 | mesenchymal cell proliferation (GO:0010463) | 2.31564211 |
| 89 | fatty acid elongation (GO:0030497) | 2.31479683 |
| 90 | nucleobase catabolic process (GO:0046113) | 2.30931921 |
| 91 | C21-steroid hormone metabolic process (GO:0008207) | 2.30396774 |
| 92 | histone H3-K9 demethylation (GO:0033169) | 2.29845795 |
| 93 | embryonic axis specification (GO:0000578) | 2.29430657 |
| 94 | cell wall macromolecule catabolic process (GO:0016998) | 2.29321109 |
| 95 | neural crest cell migration (GO:0001755) | 2.29130510 |
| 96 | layer formation in cerebral cortex (GO:0021819) | 2.29075518 |
| 97 | response to X-ray (GO:0010165) | 2.27701524 |
| 98 | negative regulation of activin receptor signaling pathway (GO:0032926) | 2.27163866 |
| 99 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.26868179 |
| 100 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.25966595 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.62107273 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.07035570 |
| 3 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.03865823 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.93891649 |
| 5 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.67145099 |
| 6 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.61757985 |
| 7 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.54603908 |
| 8 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.30683022 |
| 9 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.28645323 |
| 10 | FUS_26573619_Chip-Seq_HEK293_Human | 2.24248687 |
| 11 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.21540917 |
| 12 | P300_19829295_ChIP-Seq_ESCs_Human | 2.12359124 |
| 13 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.10829889 |
| 14 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.02771759 |
| 15 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.01785245 |
| 16 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.95894442 |
| 17 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.93990503 |
| 18 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.93491140 |
| 19 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.86371586 |
| 20 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.85932667 |
| 21 | EWS_26573619_Chip-Seq_HEK293_Human | 1.78522739 |
| 22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.77297649 |
| 23 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.76758408 |
| 24 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.76505664 |
| 25 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.71883013 |
| 26 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.69576875 |
| 27 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.63101054 |
| 28 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.58226655 |
| 29 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.55877134 |
| 30 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.55095458 |
| 31 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.52721369 |
| 32 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.52010404 |
| 33 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.50235463 |
| 34 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.48732623 |
| 35 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.45741435 |
| 36 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.43597754 |
| 37 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.42745701 |
| 38 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.42114231 |
| 39 | VDR_22108803_ChIP-Seq_LS180_Human | 1.41527795 |
| 40 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.41391275 |
| 41 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.41000129 |
| 42 | AR_25329375_ChIP-Seq_VCAP_Human | 1.40427322 |
| 43 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.38834711 |
| 44 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.37354852 |
| 45 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.36904815 |
| 46 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.36336338 |
| 47 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.36332749 |
| 48 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.34159145 |
| 49 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.31837947 |
| 50 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.31662255 |
| 51 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.30830175 |
| 52 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.30668268 |
| 53 | TP53_16413492_ChIP-PET_HCT116_Human | 1.29413201 |
| 54 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.28490301 |
| 55 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.27345583 |
| 56 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.27328732 |
| 57 | STAT3_23295773_ChIP-Seq_U87_Human | 1.25967099 |
| 58 | CJUN_26792858_Chip-Seq_BT549_Human | 1.25353341 |
| 59 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.24377443 |
| 60 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.22260637 |
| 61 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22035294 |
| 62 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.21553327 |
| 63 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.21303129 |
| 64 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.20418436 |
| 65 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.20009359 |
| 66 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.19849620 |
| 67 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.19725453 |
| 68 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.18304588 |
| 69 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.17076669 |
| 70 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.16771641 |
| 71 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.14468095 |
| 72 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.14310467 |
| 73 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.13481380 |
| 74 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.13478160 |
| 75 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.13294980 |
| 76 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.13027837 |
| 77 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.12522463 |
| 78 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.10085128 |
| 79 | TCF4_23295773_ChIP-Seq_U87_Human | 1.09537472 |
| 80 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.08379024 |
| 81 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 1.07346561 |
| 82 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.06350774 |
| 83 | JUN_21703547_ChIP-Seq_K562_Human | 1.06230600 |
| 84 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06135216 |
| 85 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.05489014 |
| 86 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.04893377 |
| 87 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04659311 |
| 88 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.04653345 |
| 89 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.04052914 |
| 90 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03507343 |
| 91 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.03361111 |
| 92 | KDM2B_26808549_Chip-Seq_REH_Human | 1.02384649 |
| 93 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.02148779 |
| 94 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.01590671 |
| 95 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.01414911 |
| 96 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.01414911 |
| 97 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.01216677 |
| 98 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.00919810 |
| 99 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.00356035 |
| 100 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.99394338 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006054_spinal_hemorrhage | 5.51078154 |
| 2 | MP0001984_abnormal_olfaction | 3.14484585 |
| 3 | MP0008004_abnormal_stomach_pH | 2.93404591 |
| 4 | MP0006072_abnormal_retinal_apoptosis | 2.66829693 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 2.66155101 |
| 6 | MP0002736_abnormal_nociception_after | 2.63650046 |
| 7 | MP0005647_abnormal_sex_gland | 2.51765041 |
| 8 | MP0002653_abnormal_ependyma_morphology | 2.45362687 |
| 9 | MP0004272_abnormal_basement_membrane | 2.36545690 |
| 10 | MP0008789_abnormal_olfactory_epithelium | 2.24215892 |
| 11 | MP0003119_abnormal_digestive_system | 2.22785276 |
| 12 | MP0008438_abnormal_cutaneous_collagen | 2.20347071 |
| 13 | MP0005499_abnormal_olfactory_system | 2.17570898 |
| 14 | MP0005394_taste/olfaction_phenotype | 2.17570898 |
| 15 | MP0003890_abnormal_embryonic-extraembry | 2.12593658 |
| 16 | MP0004233_abnormal_muscle_weight | 2.10385838 |
| 17 | MP0008932_abnormal_embryonic_tissue | 1.90791300 |
| 18 | MP0009053_abnormal_anal_canal | 1.78771401 |
| 19 | MP0000537_abnormal_urethra_morphology | 1.75325507 |
| 20 | MP0010368_abnormal_lymphatic_system | 1.73026512 |
| 21 | MP0005253_abnormal_eye_physiology | 1.63138463 |
| 22 | MP0009384_cardiac_valve_regurgitation | 1.58422887 |
| 23 | MP0003937_abnormal_limbs/digits/tail_de | 1.55354812 |
| 24 | MP0010094_abnormal_chromosome_stability | 1.54801528 |
| 25 | MP0005248_abnormal_Harderian_gland | 1.49489286 |
| 26 | MP0005623_abnormal_meninges_morphology | 1.48143549 |
| 27 | MP0008058_abnormal_DNA_repair | 1.47284297 |
| 28 | MP0000569_abnormal_digit_pigmentation | 1.44974705 |
| 29 | MP0005670_abnormal_white_adipose | 1.44485414 |
| 30 | MP0003693_abnormal_embryo_hatching | 1.44311357 |
| 31 | MP0004133_heterotaxia | 1.43673140 |
| 32 | MP0000778_abnormal_nervous_system | 1.43439153 |
| 33 | MP0005503_abnormal_tendon_morphology | 1.43373933 |
| 34 | MP0000751_myopathy | 1.43076105 |
| 35 | MP0002282_abnormal_trachea_morphology | 1.38628213 |
| 36 | MP0001968_abnormal_touch/_nociception | 1.37810322 |
| 37 | MP0004215_abnormal_myocardial_fiber | 1.35006823 |
| 38 | MP0003880_abnormal_central_pattern | 1.31100288 |
| 39 | MP0001293_anophthalmia | 1.30808627 |
| 40 | MP0005187_abnormal_penis_morphology | 1.30789322 |
| 41 | MP0002751_abnormal_autonomic_nervous | 1.25918666 |
| 42 | MP0000013_abnormal_adipose_tissue | 1.25903236 |
| 43 | MP0003137_abnormal_impulse_conducting | 1.25148475 |
| 44 | MP0003221_abnormal_cardiomyocyte_apopto | 1.14780667 |
| 45 | MP0002697_abnormal_eye_size | 1.13307268 |
| 46 | MP0006292_abnormal_olfactory_placode | 1.13175692 |
| 47 | MP0005257_abnormal_intraocular_pressure | 1.12695316 |
| 48 | MP0002102_abnormal_ear_morphology | 1.12115838 |
| 49 | MP0001177_atelectasis | 1.11769653 |
| 50 | MP0000428_abnormal_craniofacial_morphol | 1.10662734 |
| 51 | MP0005391_vision/eye_phenotype | 1.06856216 |
| 52 | MP0005275_abnormal_skin_tensile | 1.04282291 |
| 53 | MP0003385_abnormal_body_wall | 1.03809010 |
| 54 | MP0000462_abnormal_digestive_system | 1.01630416 |
| 55 | MP0003786_premature_aging | 1.01078882 |
| 56 | MP0001881_abnormal_mammary_gland | 0.99499921 |
| 57 | MP0000647_abnormal_sebaceous_gland | 0.98229901 |
| 58 | MP0004147_increased_porphyrin_level | 0.97970778 |
| 59 | MP0006035_abnormal_mitochondrial_morpho | 0.97399753 |
| 60 | MP0002184_abnormal_innervation | 0.96475170 |
| 61 | MP0010030_abnormal_orbit_morphology | 0.95660715 |
| 62 | MP0002234_abnormal_pharynx_morphology | 0.93249339 |
| 63 | MP0001542_abnormal_bone_strength | 0.93110462 |
| 64 | MP0001958_emphysema | 0.90616907 |
| 65 | MP0002233_abnormal_nose_morphology | 0.90227559 |
| 66 | MP0000049_abnormal_middle_ear | 0.87677522 |
| 67 | MP0002160_abnormal_reproductive_system | 0.87668156 |
| 68 | MP0004197_abnormal_fetal_growth/weight/ | 0.86438107 |
| 69 | MP0004859_abnormal_synaptic_plasticity | 0.86083240 |
| 70 | MP0010678_abnormal_skin_adnexa | 0.86064996 |
| 71 | MP0005330_cardiomyopathy | 0.85759481 |
| 72 | MP0009780_abnormal_chondrocyte_physiolo | 0.85329315 |
| 73 | MP0002734_abnormal_mechanical_nocicepti | 0.85158862 |
| 74 | MP0005645_abnormal_hypothalamus_physiol | 0.83914751 |
| 75 | MP0002972_abnormal_cardiac_muscle | 0.83137520 |
| 76 | MP0009703_decreased_birth_body | 0.82989202 |
| 77 | MP0003283_abnormal_digestive_organ | 0.80254264 |
| 78 | MP0003936_abnormal_reproductive_system | 0.79888869 |
| 79 | MP0001915_intracranial_hemorrhage | 0.79821175 |
| 80 | MP0003942_abnormal_urinary_system | 0.79531770 |
| 81 | MP0002111_abnormal_tail_morphology | 0.79469297 |
| 82 | MP0003567_abnormal_fetal_cardiomyocyte | 0.79051225 |
| 83 | MP0000631_abnormal_neuroendocrine_gland | 0.77433928 |
| 84 | MP0004085_abnormal_heartbeat | 0.76341228 |
| 85 | MP0001879_abnormal_lymphatic_vessel | 0.75843191 |
| 86 | MP0003861_abnormal_nervous_system | 0.75782718 |
| 87 | MP0005423_abnormal_somatic_nervous | 0.75670835 |
| 88 | MP0003755_abnormal_palate_morphology | 0.75626591 |
| 89 | MP0009697_abnormal_copulation | 0.75469436 |
| 90 | MP0009250_abnormal_appendicular_skeleto | 0.74832611 |
| 91 | MP0002092_abnormal_eye_morphology | 0.73833069 |
| 92 | MP0001286_abnormal_eye_development | 0.73654436 |
| 93 | MP0005620_abnormal_muscle_contractility | 0.73370089 |
| 94 | MP0003115_abnormal_respiratory_system | 0.72877174 |
| 95 | MP0002896_abnormal_bone_mineralization | 0.71253417 |
| 96 | MP0003279_aneurysm | 0.71088428 |
| 97 | MP0000427_abnormal_hair_cycle | 0.70914006 |
| 98 | MP0003329_amyloid_beta_deposits | 0.69350687 |
| 99 | MP0002735_abnormal_chemical_nociception | 0.69206512 |
| 100 | MP0001672_abnormal_embryogenesis/_devel | 0.68612141 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Progressive inability to walk (HP:0002505) | 5.73841634 |
| 2 | Congenital primary aphakia (HP:0007707) | 4.98307991 |
| 3 | Gait imbalance (HP:0002141) | 4.92055645 |
| 4 | Male infertility (HP:0003251) | 4.58730126 |
| 5 | Medial flaring of the eyebrow (HP:0010747) | 4.49333722 |
| 6 | Nephrogenic diabetes insipidus (HP:0009806) | 4.22262955 |
| 7 | Premature rupture of membranes (HP:0001788) | 3.59204301 |
| 8 | Shoulder girdle muscle weakness (HP:0003547) | 3.54840356 |
| 9 | Poor coordination (HP:0002370) | 3.53821278 |
| 10 | Vaginal atresia (HP:0000148) | 3.48806254 |
| 11 | Genital tract atresia (HP:0001827) | 3.48571728 |
| 12 | Abnormality of the musculature of the pelvis (HP:0001469) | 3.40442373 |
| 13 | Abnormality of the hip-girdle musculature (HP:0001445) | 3.40442373 |
| 14 | Decreased testicular size (HP:0008734) | 3.15426728 |
| 15 | Aplasia/Hypoplasia of the lens (HP:0008063) | 3.10709542 |
| 16 | Pelvic girdle muscle weakness (HP:0003749) | 3.06020257 |
| 17 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.98258538 |
| 18 | Abnormality of alanine metabolism (HP:0010916) | 2.98258538 |
| 19 | Hyperalaninemia (HP:0003348) | 2.98258538 |
| 20 | Entropion (HP:0000621) | 2.85981440 |
| 21 | Fused cervical vertebrae (HP:0002949) | 2.85479687 |
| 22 | Inability to walk (HP:0002540) | 2.80487320 |
| 23 | Limb-girdle muscle atrophy (HP:0003797) | 2.76203295 |
| 24 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.67012792 |
| 25 | Abnormality of glycolysis (HP:0004366) | 2.62327981 |
| 26 | Broad foot (HP:0001769) | 2.61319120 |
| 27 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.60468143 |
| 28 | Increased serum pyruvate (HP:0003542) | 2.60451337 |
| 29 | Carpal bone hypoplasia (HP:0001498) | 2.57387481 |
| 30 | Gonadotropin excess (HP:0000837) | 2.52535598 |
| 31 | Abnormal auditory evoked potentials (HP:0006958) | 2.43133683 |
| 32 | Short tibia (HP:0005736) | 2.39444884 |
| 33 | Abnormality of abdominal situs (HP:0011620) | 2.38723092 |
| 34 | Abdominal situs inversus (HP:0003363) | 2.38723092 |
| 35 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.38437249 |
| 36 | Dental crowding (HP:0000678) | 2.38203092 |
| 37 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.37378900 |
| 38 | Ankle contracture (HP:0006466) | 2.36296536 |
| 39 | Short 1st metacarpal (HP:0010034) | 2.34861788 |
| 40 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.34861788 |
| 41 | Spastic diplegia (HP:0001264) | 2.32878443 |
| 42 | Leiomyosarcoma (HP:0100243) | 2.15538750 |
| 43 | Uterine leiomyosarcoma (HP:0002891) | 2.15538750 |
| 44 | Abnormality of the parathyroid morphology (HP:0011766) | 2.15393808 |
| 45 | Anosmia (HP:0000458) | 2.11974768 |
| 46 | Limb-girdle muscle weakness (HP:0003325) | 2.11884147 |
| 47 | Astigmatism (HP:0000483) | 2.10866021 |
| 48 | Adrenal hypoplasia (HP:0000835) | 2.10346293 |
| 49 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.09872073 |
| 50 | Abnormality of dentin (HP:0010299) | 2.07474124 |
| 51 | Micropenis (HP:0000054) | 2.07105633 |
| 52 | Specific learning disability (HP:0001328) | 2.03503035 |
| 53 | Abnormality of the nasal septum (HP:0000419) | 2.02236232 |
| 54 | Increased variability in muscle fiber diameter (HP:0003557) | 2.02101504 |
| 55 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.01368916 |
| 56 | Short foot (HP:0001773) | 2.01333612 |
| 57 | Amyotrophic lateral sclerosis (HP:0007354) | 1.99184186 |
| 58 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.98694563 |
| 59 | Pancreatic cysts (HP:0001737) | 1.98597605 |
| 60 | Cortical dysplasia (HP:0002539) | 1.98153140 |
| 61 | Follicular hyperkeratosis (HP:0007502) | 1.97960625 |
| 62 | Ectopic kidney (HP:0000086) | 1.97102834 |
| 63 | Abnormality of the 1st metacarpal (HP:0010009) | 1.96203764 |
| 64 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.95903385 |
| 65 | Male pseudohermaphroditism (HP:0000037) | 1.94757771 |
| 66 | Hypoplastic pelvis (HP:0008839) | 1.94513851 |
| 67 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.94489245 |
| 68 | Pancreatic fibrosis (HP:0100732) | 1.93793928 |
| 69 | Left ventricular hypertrophy (HP:0001712) | 1.91704615 |
| 70 | Horseshoe kidney (HP:0000085) | 1.89612643 |
| 71 | Short nail (HP:0001799) | 1.89183011 |
| 72 | Termporal pattern (HP:0011008) | 1.84732333 |
| 73 | Insidious onset (HP:0003587) | 1.84732333 |
| 74 | Short humerus (HP:0005792) | 1.83550259 |
| 75 | Aganglionic megacolon (HP:0002251) | 1.82768358 |
| 76 | Bladder carcinoma (HP:0002862) | 1.82271153 |
| 77 | Bladder neoplasm (HP:0009725) | 1.82271153 |
| 78 | Abnormal biliary tract physiology (HP:0012439) | 1.80837438 |
| 79 | Bile duct proliferation (HP:0001408) | 1.80837438 |
| 80 | True hermaphroditism (HP:0010459) | 1.80604479 |
| 81 | Hypoplasia of the iris (HP:0007676) | 1.80440850 |
| 82 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.79540216 |
| 83 | Postaxial hand polydactyly (HP:0001162) | 1.78786692 |
| 84 | Bifid tongue (HP:0010297) | 1.78230895 |
| 85 | Supernumerary spleens (HP:0009799) | 1.77340579 |
| 86 | Soft skin (HP:0000977) | 1.77047051 |
| 87 | Delayed gross motor development (HP:0002194) | 1.76263456 |
| 88 | Thyroid-stimulating hormone excess (HP:0002925) | 1.74843064 |
| 89 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.72345665 |
| 90 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.71398892 |
| 91 | Preaxial hand polydactyly (HP:0001177) | 1.70685426 |
| 92 | Slender build (HP:0001533) | 1.69997916 |
| 93 | Small hand (HP:0200055) | 1.69470908 |
| 94 | Vitreoretinal degeneration (HP:0000655) | 1.68028752 |
| 95 | Meckel diverticulum (HP:0002245) | 1.66520841 |
| 96 | Intellectual disability, moderate (HP:0002342) | 1.66328649 |
| 97 | Abnormality of the calf musculature (HP:0001430) | 1.64376262 |
| 98 | Short clavicles (HP:0000894) | 1.60136737 |
| 99 | Fibular hypoplasia (HP:0003038) | 1.60047276 |
| 100 | Morphological abnormality of the middle ear (HP:0008609) | 1.59676697 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERBB4 | 7.56885932 |
| 2 | SRPK1 | 6.62306944 |
| 3 | PDK2 | 4.01507081 |
| 4 | GRK7 | 3.92962614 |
| 5 | LATS1 | 2.69268593 |
| 6 | CSNK1A1L | 2.07224306 |
| 7 | CSNK1G3 | 2.02404731 |
| 8 | BCR | 1.92996126 |
| 9 | NEK9 | 1.90586446 |
| 10 | PLK2 | 1.85871766 |
| 11 | EIF2AK3 | 1.79536074 |
| 12 | TESK1 | 1.74180643 |
| 13 | CSNK1G1 | 1.66704147 |
| 14 | CSNK1G2 | 1.65835152 |
| 15 | TRIM28 | 1.64441797 |
| 16 | EIF2AK1 | 1.61237623 |
| 17 | TSSK6 | 1.60910828 |
| 18 | PAK4 | 1.56124491 |
| 19 | LIMK1 | 1.55251850 |
| 20 | PLK4 | 1.46159889 |
| 21 | RPS6KA4 | 1.35385444 |
| 22 | FER | 1.19509650 |
| 23 | CDC7 | 1.17075500 |
| 24 | NUAK1 | 1.09417405 |
| 25 | PAK6 | 1.05298604 |
| 26 | TESK2 | 1.04280934 |
| 27 | GRK1 | 0.97736182 |
| 28 | MOS | 0.95713034 |
| 29 | PAK3 | 0.94639811 |
| 30 | ERBB3 | 0.90802040 |
| 31 | CAMKK2 | 0.90771072 |
| 32 | CCNB1 | 0.90762219 |
| 33 | BRSK2 | 0.90228936 |
| 34 | EIF2AK2 | 0.90131059 |
| 35 | MYLK | 0.87753768 |
| 36 | BRD4 | 0.87660169 |
| 37 | WNK3 | 0.86129132 |
| 38 | BUB1 | 0.84365721 |
| 39 | ADRBK1 | 0.83729942 |
| 40 | PLK3 | 0.83564181 |
| 41 | BRSK1 | 0.83107932 |
| 42 | DDR2 | 0.82062481 |
| 43 | PBK | 0.80271331 |
| 44 | STK16 | 0.79792950 |
| 45 | TGFBR2 | 0.72826541 |
| 46 | TNIK | 0.72310931 |
| 47 | CDK6 | 0.72091804 |
| 48 | FGR | 0.70488049 |
| 49 | PLK1 | 0.70255690 |
| 50 | DYRK3 | 0.70034636 |
| 51 | MKNK1 | 0.65698670 |
| 52 | EPHA4 | 0.65597469 |
| 53 | EPHB1 | 0.62297847 |
| 54 | CAMK2B | 0.59957877 |
| 55 | GRK5 | 0.59424538 |
| 56 | EPHB2 | 0.59161823 |
| 57 | ROCK2 | 0.59142579 |
| 58 | TTK | 0.57024528 |
| 59 | NEK1 | 0.56461278 |
| 60 | CDK9 | 0.55978569 |
| 61 | MARK1 | 0.55171201 |
| 62 | DYRK2 | 0.52516184 |
| 63 | DAPK1 | 0.51310052 |
| 64 | ERBB2 | 0.51228252 |
| 65 | CDK19 | 0.49607866 |
| 66 | CAMK2A | 0.49550686 |
| 67 | DYRK1A | 0.48536476 |
| 68 | STK10 | 0.48125990 |
| 69 | CDK12 | 0.45319477 |
| 70 | CDK14 | 0.44363272 |
| 71 | CASK | 0.44111719 |
| 72 | FRK | 0.44086055 |
| 73 | CDK18 | 0.43864324 |
| 74 | STK38L | 0.43519296 |
| 75 | AURKA | 0.43161095 |
| 76 | PINK1 | 0.41745168 |
| 77 | PKN1 | 0.41578618 |
| 78 | STK3 | 0.40416735 |
| 79 | LATS2 | 0.39728895 |
| 80 | WEE1 | 0.39635943 |
| 81 | CDK15 | 0.39026376 |
| 82 | PRKCE | 0.37879770 |
| 83 | CDK11A | 0.36471923 |
| 84 | PTK2B | 0.35947479 |
| 85 | AKT2 | 0.35574112 |
| 86 | PRKCG | 0.34158539 |
| 87 | GSK3A | 0.33509449 |
| 88 | CSNK1D | 0.32519304 |
| 89 | MAP4K2 | 0.31908177 |
| 90 | AURKB | 0.31286991 |
| 91 | PTK6 | 0.31026134 |
| 92 | CSNK1A1 | 0.30040303 |
| 93 | CAMK2G | 0.29127170 |
| 94 | PDGFRA | 0.27903411 |
| 95 | CDK5 | 0.26740756 |
| 96 | CHEK1 | 0.25402595 |
| 97 | CDK3 | 0.24097172 |
| 98 | MAP3K12 | 0.22584514 |
| 99 | CHEK2 | 0.22099067 |
| 100 | VRK2 | 0.21350046 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Mismatch repair_Homo sapiens_hsa03430 | 2.83336848 |
| 2 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.64761934 |
| 3 | Homologous recombination_Homo sapiens_hsa03440 | 2.40957966 |
| 4 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.27760950 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.27062887 |
| 6 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.21701070 |
| 7 | Basal cell carcinoma_Homo sapiens_hsa05217 | 2.05531071 |
| 8 | Nicotine addiction_Homo sapiens_hsa05033 | 2.05490284 |
| 9 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.02192169 |
| 10 | DNA replication_Homo sapiens_hsa03030 | 1.99552680 |
| 11 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.69969671 |
| 12 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.64991637 |
| 13 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.60828144 |
| 14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.60674381 |
| 15 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.58500026 |
| 16 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.58143403 |
| 17 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.57465774 |
| 18 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.56254996 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.53873332 |
| 20 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.52654019 |
| 21 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.52272865 |
| 22 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.50822394 |
| 23 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.49606659 |
| 24 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.47082364 |
| 25 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.42033945 |
| 26 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.41359073 |
| 27 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.40937551 |
| 28 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.40527209 |
| 29 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.35343377 |
| 30 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.31617372 |
| 31 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.30821141 |
| 32 | Adherens junction_Homo sapiens_hsa04520 | 1.28472533 |
| 33 | Spliceosome_Homo sapiens_hsa03040 | 1.14957566 |
| 34 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.06436345 |
| 35 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.06365684 |
| 36 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.06163834 |
| 37 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.05927843 |
| 38 | Tight junction_Homo sapiens_hsa04530 | 1.05372367 |
| 39 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.00903307 |
| 40 | Lysine degradation_Homo sapiens_hsa00310 | 0.99483057 |
| 41 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.99466001 |
| 42 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.97601550 |
| 43 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.97520658 |
| 44 | Cell cycle_Homo sapiens_hsa04110 | 0.97030096 |
| 45 | Phototransduction_Homo sapiens_hsa04744 | 0.95704012 |
| 46 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.95564362 |
| 47 | GABAergic synapse_Homo sapiens_hsa04727 | 0.95289424 |
| 48 | RNA polymerase_Homo sapiens_hsa03020 | 0.95251965 |
| 49 | Olfactory transduction_Homo sapiens_hsa04740 | 0.94113071 |
| 50 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.89188184 |
| 51 | Basal transcription factors_Homo sapiens_hsa03022 | 0.88855432 |
| 52 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.86202196 |
| 53 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.86141678 |
| 54 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.86002498 |
| 55 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.85510286 |
| 56 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.83996882 |
| 57 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.83086847 |
| 58 | Melanogenesis_Homo sapiens_hsa04916 | 0.77972717 |
| 59 | Focal adhesion_Homo sapiens_hsa04510 | 0.77086363 |
| 60 | Proteasome_Homo sapiens_hsa03050 | 0.76105413 |
| 61 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.75696020 |
| 62 | Melanoma_Homo sapiens_hsa05218 | 0.73760858 |
| 63 | Carbon metabolism_Homo sapiens_hsa01200 | 0.72805784 |
| 64 | Axon guidance_Homo sapiens_hsa04360 | 0.71069706 |
| 65 | RNA transport_Homo sapiens_hsa03013 | 0.70584325 |
| 66 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.70277626 |
| 67 | Base excision repair_Homo sapiens_hsa03410 | 0.69265290 |
| 68 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.68957249 |
| 69 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68721479 |
| 70 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.67860535 |
| 71 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.65379991 |
| 72 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.63395039 |
| 73 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.61853114 |
| 74 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.61660378 |
| 75 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.61634421 |
| 76 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.60823095 |
| 77 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.59080730 |
| 78 | RNA degradation_Homo sapiens_hsa03018 | 0.58660323 |
| 79 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.58350754 |
| 80 | Colorectal cancer_Homo sapiens_hsa05210 | 0.58227824 |
| 81 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.55850130 |
| 82 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.53379561 |
| 83 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.53351787 |
| 84 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.53208565 |
| 85 | Alcoholism_Homo sapiens_hsa05034 | 0.52536222 |
| 86 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.52127401 |
| 87 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.52041897 |
| 88 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52003567 |
| 89 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.50765435 |
| 90 | Taste transduction_Homo sapiens_hsa04742 | 0.50217017 |
| 91 | Thyroid cancer_Homo sapiens_hsa05216 | 0.49964407 |
| 92 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.49938648 |
| 93 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.49416891 |
| 94 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.48613402 |
| 95 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.48170958 |
| 96 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.47752829 |
| 97 | Gap junction_Homo sapiens_hsa04540 | 0.47350617 |
| 98 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.46896274 |
| 99 | Circadian entrainment_Homo sapiens_hsa04713 | 0.43538950 |
| 100 | Morphine addiction_Homo sapiens_hsa05032 | 0.42583710 |

